Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Nov;135(5):1153-1160.
doi: 10.1016/j.bja.2025.07.035. Epub 2025 Jul 31.

Robotic process automation to identify patients at high risk for perioperative myocardial infarction or injury: a prospective, blinded, paired reader-controlled single-centre study

Affiliations
Observational Study

Robotic process automation to identify patients at high risk for perioperative myocardial infarction or injury: a prospective, blinded, paired reader-controlled single-centre study

Koray Durak et al. Br J Anaesth. 2025 Nov.

Abstract

Background: Although current guidelines recommend active surveillance for perioperative myocardial infarction, injury, or both in high-risk patients, implementation remains limited in most institutions worldwide because of a lack of resources.

Methods: We hypothesised that robotic process automation (RPA), a software technology that enables virtual bots to replicate human tasks within digital systems, could accurately replace experienced clinical staff. Manual screening by experienced clinical staff and RPA screening were carried out simultaneously and blinded to identify high-risk patients eligible for active surveillance for myocardial infarction/injury, according to predefined screening criteria. Discrepant identification was reviewed by an independent clinician blinded to the origin of the identification, generating a reference standard classification of paired reader-controlled patients to investigate the primary diagnostic endpoint: relative true positive fraction.

Results: In 660 participants (median age 60 yr, interquartile range 42-73 yr, 54.8% female), 77/660 (12%) were eligible for active surveillance for perioperative myocardial infarction or injury according to the reference standard classification. RPA screening achieved 75 (97%) true positive identifications, compared with 63 (82%) identified from manual screening (relative true positive fraction: 1.19, 95% confidence interval 1.08-1.32, P=0.004). The number needed to screen to identify one additional true positive using RPA screening was 6. RPA screening had a sensitivity of 0.97 (0.91-0.99), compared with 0.82 (0.72-0.89) for. Both approaches had high specificity (RPA screening: 0.98 [0.97-0.99], compared with manual screening: 1.0 [0.99-1.00]). The estimated annual cost of RPA screening was 81% lower compared with manual screening.

Conclusions: RPA screening was superior to standard-of-care manual screening by experienced clinical staff in identifying patients at high risk for perioperative myocardial infarction or injury.

Clinical trial registration: NCT02573532.

Keywords: active surveillance; myocardial injury after noncardiac surgery; perioperative care; perioperative myocardial infarction; perioperative myocardial injury; robotic process automation.

PubMed Disclaimer

Conflict of interest statement

Declarations of interest CM reports research grants from the Swiss Heart Foundation, the Swiss National Science Foundation, the University Hospital Basel, the University of Basel, Innosuisse, Abbott, AstraZeneca, Beckman Coulter, Boehringer Ingelheim, BRAHMS Thermo Fisher Scientific, Idorsia, LSI Medience Corporation, Novartis, Ortho Diagnostics, Quidel, Roche, Siemens, Singulex, SpinChip, Sphingotec, and speaker honoraria/consulting honoraria from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Idorsia, Novartis, Novo Nordisk, Osler, Roche, SpinChip, and Sanofi, all paid to the institution. CP reports grants from the Swiss Heart Foundation, Roche Diagnostics and the University Hospital Basel. DMG has received speaker or consulting honoraria from Roche, outside the submitted work. FM has been supported by Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939), and Deutsche Herzstiftung. Saarland University has received scientific support from Ablative Solutions, Medtronic, and ReCor Medical. Until May 2024, FM has received speaker honoraria/consulting fees from Ablative Solutions, Astra Zeneca, Inari, Medtronic, Merck, Novartis, Philips, and ReCor Medical. NG reports grants from the Swiss Heart Foundation. CP reports grants from the Swiss Heart Foundation, Roche Diagnostics and the University Hospital Basel dedicated to conduct of this study, and chaired an advisory board for Roche Diagnostics, during the conduct of the study. All other authors declare that they have no conflicts of interest.

Figures

Fig 1
Fig 1
Screening criteria of patients scheduled for surgery. (a) High-risk and inclusion criteria for PMI surveillance. All criteria must be met. (b) Low-risk and exclusion criteria. Meeting any one of these is sufficient to exclude a participant from PMI surveillance, even if inclusion criteria are fulfilled. PMI, perioperative myocardial infarction or injury.
Fig 2
Fig 2
Reference standard classification. (a) Flowchart of participant classification and adjudication process. In cases where RPA screening and MS agreed, participants were directly included or excluded based on that consensus. Discrepant identifications were reviewed in a paired reader control process by an independent clinician blinded to the screening method. Finally, the reference standard classification was based on agreement among at least two of the three sources: RPA screening, MS, and the independent clinician. (b) Alluvial plot illustrating agreement and discrepancies between all methods. MS, manual screening; Ref, reference standard; RPA, robotic process automation.
Fig 3
Fig 3
Diagnostic accuracy of RPA screening vs manual screening for identifying participants at high risk for PMI. Comparative forest plot of sensitivity and true positive identification rates between RPA screening and MS, displayed as relative true positive fraction (i.e. the number of true positive identifications by manual screening and RPA screening divided by the number of true positive cases according to the reference standard classification). All estimates are presented with corresponding 95% confidence intervals. The striped line indicates the predefined non-inferiority margin of 0.9. MS, manual screening; PMI, perioperative myocardial infarction/injury; RPA, robotic process automation.
Fig 4
Fig 4
Keyword-based participant identification by robotic process automation screening. Bar plot of high-risk and eligible participants identified by robotic process automation screening based on keyword extraction from preoperative anaesthesia assessments and medical records. PMI, perioperative myocardial infarction/injury.

References

    1. Nepogodiev D., Martin J., Biccard B., et al. Global burden of postoperative death. Lancet. 2019;393:401. - PubMed
    1. Puelacher C., Lurati Buse G., Seeberger D., et al. Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization. Circulation. 2018;137:1221–1232. - PubMed
    1. Botto F., Alonso-Coello P., Chan M.T.V., et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120:564–578. - PubMed
    1. Devereaux P.J., Chan M.T.V., Alonso-Coello P., et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295–2304. - PubMed
    1. Beattie W.S., Karkouti K., Tait G., et al. Use of clinically based troponin underestimates the cardiac injury in non-cardiac surgery: a single-centre cohort study in 51,701 consecutive patients. Can J Anaesth. 2012;59:1013–1022. - PubMed

Publication types

Associated data